What is Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap?

Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value is $3.5B, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$152.1M, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA?

Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA is -$161.7M, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.36, based on as-reported figures from SEC (XBRL) filings.

What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt?

Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt is -$250.8M, based on as-reported figures from SEC (XBRL) filings.

Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) Financial Statements

Amylyx Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00DP10YW1

XNAS · usd

33.88▼ 0.22 (-0.65%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close34.10

Day's Range33.10 – 34.72

52-Week Range10.07 – 41.14

Volume1.1M

Avg Volume3.2M

Share Statistics

Shares Outstanding

Employees136

ExchangeXNAS

Listed2022-01-07

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)

What is Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap?: Amylyx Pharmaceuticals, Inc. Common Stock's Market Cap is $3.8B, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Amylyx Pharmaceuticals, Inc. Common Stock's Enterprise Value is $3.5B, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Amylyx Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$152.1M, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA?: Amylyx Pharmaceuticals, Inc. Common Stock's EBITDA is -$161.7M, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Amylyx Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.36, based on as-reported figures from SEC (XBRL) filings.
What is Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt?: Amylyx Pharmaceuticals, Inc. Common Stock's Net Debt is -$250.8M, based on as-reported figures from SEC (XBRL) filings.